等待開盤 07-21 09:30:00 美东时间
+0.620
+1.41%
Cimpress NV ( ($CMPR) ) has released its Q2 earnings. Here is a breakdown of th...
01-31 11:55
Oppenheimer:上调Ovid Therapeutics(OVID)评级至"跑赢大市",目标价4美元
01-30 16:06
Cimpress (NASDAQ:CMPR) released its Q2 earnings on Wednesday, January 29, 2025 ...
01-30 05:36
The earnings results for Cimpress (NASDAQ:CMPR) for Q2 were made public on Wedn...
01-30 05:30
The Q2 earnings report for Cimpress (NASDAQ:CMPR) was released on Wednesday, Ja...
01-30 05:25
Cimpress (NASDAQ:CMPR) reported quarterly earnings of $2.36 per share which missed the analyst consensus estimate of $2.43 by 2.88 percent. This is a 10.28 percent increase over earnings of $2.14 per share from the same
01-30 05:12
Companies Reporting Before The Bell • Stifel Financial (NYSE:SF) is likely to r...
01-29 16:32
<span> <meta content="no-referrer" name="referrer"></span><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Rosenblatt:上调Innoviz Technologies(INVZ)评级至"买入",目标价从3.25美元升至4美元</p> <p>• B. Riley证券:上调Cognition Therapeutics(CGTX)评级至"买入",目标价从1美元升至1.5美元</p> <p>• 富国银行:维持Ultragenyx制药(RARE)"超配"评级,目标价从75美元升至88美元</p> <p>• Maxim Group:首予Tru
2024-12-23 09:29
Analyst Kevin Steinke of Barrington reiterated a Buy rating on Cimpress (CMPR –...
2024-12-21 02:29